Malpapharm Ltd in Manchester, M20 6JW

Description

Data updated on: 01-11-2023

Registered with number 07631998 13 years ago, Malpapharm Ltd is a Private Limited Company. The firm's official registration address is 117 Atwood Road, Didsbury Manchester. The company's SIC code is 47730 which stands for Dispensing chemist in specialised stores. The firm's most recent filed accounts documents cover the period up to 2022-10-31 and the most recent annual confirmation statement was submitted on 2023-06-26.

Current directors enumerated by the following limited company are: Max D. selected to lead the company in 2023 and Malcolm B. selected to lead the company on 2011-05-12.

The companies that control this firm are as follows: Malpapharm Holdings Ltd owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Manchester at Atwood Road, M20 6JW and was registered as a PSC under the registration number 12578662.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2012-10-31	2013-10-31	2014-10-31	2015-10-31	2016-10-31	2017-10-31	2018-10-31	2019-10-31	2020-10-31	2021-10-31	2022-10-31
Currency	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP	GBP
Net Worth	20 559	54 543	82 301	65 552	133 815

Balance Sheet
Cash Bank On Hand					97 618	52 362	58 838	60 785	292 933	252 319	108 711
Current Assets	236 259	322 343	379 545	448 527	505 746	402 790	563 864	606 536	706 813	1 179 316	859 895
Debtors	175 252	211 272	159 839	196 204	337 154	277 529	438 945	473 843	345 896	858 130	685 303
Net Assets Liabilities					133 815	120 349	109 654	100 002	76 319	239 430	29 202
Other Debtors					185 714	146 876	23 373	26 138	34 142	44 908	40 882
Property Plant Equipment					92 836	86 457	69 755	52 999	28 491	11 814	6 376
Total Inventories					70 974	72 899	66 081	71 908	67 984	68 867	65 881
Cash Bank In Hand	22 712	63 044	168 877	174 775	97 618
Net Assets Liabilities Including Pension Asset Liability	20 559	54 543	82 301	65 552	133 815
Stocks Inventory	38 295	48 027	50 829	77 548	70 974
Tangible Fixed Assets	92 731	81 160	69 187	65 344	92 836

Capital & Reserves
Called Up Share Capital	2	3	3	3	3
Profit Loss Account Reserve	20 557	54 540	82 298	65 549	133 812
Shareholder Funds	20 559	54 543	82 301	65 552	133 815

Other Financial Data
Version Production Software									2 020		2 023
Accrued Liabilities										1 335	1 157
Accumulated Amortisation Impairment Intangible Assets											319 559
Accumulated Depreciation Impairment Property Plant Equipment					70 516	91 923	113 912	136 195	162 250	180 176	185 614
Additions Other Than Through Business Combinations Property Plant Equipment						15 028	5 287	5 527	1 547	1 249
Amounts Owed By Group Undertakings Participating Interests										405 508	405 508
Average Number Employees During Period					25	25	26	28	29	25	35
Bank Borrowings										339 333	300 183
Bank Borrowings Overdrafts										83 333	111 831
Creditors					464 767	368 898	523 965	559 533	599 142	612 367	536 886
Deferred Income									73 880
Finished Goods Goods For Resale					70 974	72 899	66 081	71 908	67 984
Increase From Amortisation Charge For Year Intangible Assets											319 559
Increase From Depreciation Charge For Year Property Plant Equipment						21 407	21 989	22 283	26 055	17 926	5 438
Intangible Assets Gross Cost											319 559
Loans From Directors					111 512	87 992	90 117	97 228	122 634	2 419	100 482
Net Current Assets Liabilities	27 944	-17 715	20 557	7 680	40 979	33 892	39 899	47 003	107 671	566 949	323 009
Nominal Value Allotted Share Capital					1	1	1	1	2	2	2
Nominal Value Shares Issued In Period							1
Number Shares Allotted	2	3	3	3	1	1	1	1	2	2	2
Number Shares Issued In Period- Gross							1
Other Creditors					842	547	134 092	141 907	139 767	194 500	6 800
Par Value Share	1	1	1	1	1	1	1	1	1	1	1
Property Plant Equipment Gross Cost					163 352	178 380	183 667	189 194	190 741	191 990	191 990
Taxation Social Security Payable					47 608	26 450	29 456	34 157	54 935	54 859	3 910
Total Additions Including From Business Combinations Intangible Assets											319 559
Total Assets Less Current Liabilities	120 675	63 445	89 744	73 024	133 815				76 319	578 763	329 385
Trade Creditors Trade Payables					304 805	253 909	270 300	286 241	281 806	275 921	312 706
Trade Debtors Trade Receivables					151 440	130 653	415 572	447 705	311 754	407 714	238 913
Creditors Due After One Year	90 000
Creditors Due Within One Year	208 315	340 058	358 988	440 847	464 767
Fixed Assets	92 731	81 160	69 187	65 344	92 836
Provisions For Liabilities Charges	10 116	8 902	7 443	7 472
Share Capital Allotted Called Up Paid	2	3	3	3	1
Tangible Fixed Assets Additions	105 360	1 222	984	11 086	44 700
Tangible Fixed Assets Cost Or Valuation	105 360	106 582	107 566	118 652	163 352
Tangible Fixed Assets Depreciation	12 629	25 422	38 379	53 308	70 516
Tangible Fixed Assets Depreciation Charged In Period	12 629	12 793	12 957	14 929	17 208

Company staff

Max D.

Role: Director

Appointed: 05 May 2023

Latest update: 13 April 2024

Malcolm B.

Role: Director

Appointed: 12 May 2011

Latest update: 13 April 2024

People with significant control

Malpapharm Holdings Ltd

Address: 117 Atwood Road, Manchester, M20 6JW, England

Legal authority Companies Act 2006

Legal form Company Limited By Shares

Country registered England

Place registered England And Wales

Registration number 12578662

Notified on 22 December 2020

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Malcolm B.

Notified on 6 April 2016

Ceased on 22 December 2020

Nature of control:

1/2 or less of shares

Paul B.

Notified on 6 April 2016

Ceased on 22 December 2020

Nature of control:

1/2 or less of shares

Accounts Documents

Account next due date	31 July 2024
Account last made up date	31 October 2022
Confirmation statement next due date	10 July 2024
Confirmation statement last made up date	26 June 2023

Annual Accounts 11 February 2013
Start Date For Period Covered By Report	2011-05-12
End Date For Period Covered By Report	2012-10-31
Date Approval Accounts	11 February 2013
Annual Accounts 05 February 2014
Start Date For Period Covered By Report	2012-11-01
End Date For Period Covered By Report	2013-10-31
Date Approval Accounts	05 February 2014
Annual Accounts 21 January 2015
Start Date For Period Covered By Report	2013-11-01
End Date For Period Covered By Report	2014-10-31
Date Approval Accounts	21 January 2015
Annual Accounts 08 February 2016
Start Date For Period Covered By Report	2014-11-01
End Date For Period Covered By Report	2015-10-31
Date Approval Accounts	08 February 2016
Annual Accounts 22 February 2017
Start Date For Period Covered By Report	2015-11-01
End Date For Period Covered By Report	2016-10-31
Date Approval Accounts	22 February 2017
Annual Accounts
Start Date For Period Covered By Report	1 November 2017
End Date For Period Covered By Report	31 October 2018
Annual Accounts
Start Date For Period Covered By Report	1 November 2018
End Date For Period Covered By Report	31 October 2019
Annual Accounts
Start Date For Period Covered By Report	1 November 2019
End Date For Period Covered By Report	31 October 2020
Annual Accounts
Start Date For Period Covered By Report	1 November 2020
End Date For Period Covered By Report	31 October 2021
Annual Accounts
Start Date For Period Covered By Report	1 November 2021
End Date For Period Covered By Report	31 October 2022
Annual Accounts
End Date For Period Covered By Report	31 October 2017

Malpapharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Max D.

Malcolm B.

Paul B.

People with significant control

Malpapharm Holdings Ltd

Malcolm B.

Paul B.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies